Product Information
VENLAFAXINE HCL ER 37.5 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.4623 per EA under NDC 68001049604. Its NADAC has been published 251 times since Nov 3, 2021.
FDA first approved this application on Oct 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001049604
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214419FDA Approved
10/21/2020
TE Code
AB
On Market Since
4/30/2021
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has been published 251 times since Nov 3, 2021, and over the history we have for it it has declined 76.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4623 per EA |
|---|---|
| All-time high | $3.1951 (Jun 15, 2022) |
| All-time low | $0.3039 (Jan 22, 2025) |
| 52-week high | $0.6512 |
| 52-week low | $0.3302 |
| Median price | $0.8390 |
| Average price | $1.0618 |
| Largest weekly change | +62.8% (May 18, 2022) |
| Weeks tracked | 251 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG TAB, manufactured by BluePoint Laboratories, is $0.4623 per EA (NDC 68001049604), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has declined 76.4%. It has been tracked across 251 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG TAB?
Since Nov 3, 2021, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has ranged from a low of $0.3039 (Jan 22, 2025) to a high of $3.1951 (Jun 15, 2022), with a median of $0.8390 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0743 per EA — about 84% below VENLAFAXINE HCL ER 37.5 MG TAB.
Who manufactures VENLAFAXINE HCL ER 37.5 MG TAB?
VENLAFAXINE HCL ER 37.5 MG TAB (NDC 68001049604) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.